Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | RANIRani Therapeutics Holdings, Inc.FY2025 · Dec |
|---|---|
| Revenue | $1.63M |
| Revenue, yoy | +58.9% |
| Net income | $29.67M |
| Net income, yoy | +1.1% |
| Net margin | -1,817.1% |
| Free cash flow | $18.80M |
| FCF margin | -1,151.4% |
| EPS, diluted | $0.45 |
Add another company.